The table below shows Guardant Health, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$982.02M
$739.02M
$563.95M
$449.54M
$373.65M
$286.73M
Cost of revenue
$349.01M
$289.80M
$227.05M
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$364.19M
$347.75M
$367.19M
$373.81M
$263.22M
$149.86M
SG&A
GH annual revenue (10-K history)
Guardant Health, Inc. reported annual revenue of $982.02M for fiscal year 2025. That is up 32.9% from $739.02M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $25.25M (FY 2016) to $982.02M. Figures come from the company's audited annual reports as filed with the SEC.
